参考文献/References:
[1]陈万青,李贺,孙可欣,等.2014年中国恶性肿瘤发病和死亡分析[J].中华肿瘤杂志,2018,40(1):5-13. [2]Velez-Cubian FO,Rodriguez KL,Thau MR,et al.Efficacy of lymph node dissection during robotic-assisted lobectomy for non-small cell lung cancer:retrospective review of 159 consecutive cases[J].J Thorac Dis,2016,8(9):2454-2463. [3]Lim E,Baldwin D,Beckles M,et al.Guidelines on the radical management of patients with lung cancer[J].Thorax,2010,65(Suppl 3):iii1-iii27. [4]Nguyen D,Gharagozloo F,Tempesta B,et al.Long-term results of robotic anatomical segmentectomy for early-stage non-small-cell lung cancer[J].Eur J Cardiothorac Surg,2019,55(3):427-433. [5]Li C,Han Y,Han D,et al.Robotic Approach to Combined Anatomic Pulmonary Subsegmentectomy:Technical Aspects and Early Results[J].Ann Thorac Surg,2019,107(5):1480-1486. [6]Kagimoto A,Tsutani Y,Izaki Y,et al.Initial experience of robotic anatomical segmentectomy for non-small cell lung cancer[J].Jpn J Clin Oncol,2020,50(4):440-445. [7]Kneuertz PJ,D’Souza DM,Richardson M,et al.Long-Term Oncologic Outcomes After Robotic Lobectomy for Early-stage Non-Small-cell Lung Cancer Versus Video-assisted Thoracoscopic and Open Thoracotomy Approach[J].Clin Lung Cancer,2020,21(3):214-224.e2. [8]Chansky K,Detterbeck FC,Nicholson AG,et al.The IASLC Lung Cancer Staging Project:External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer[J].J Thorac Oncol,2017,12(7):1109-1121. [9]Terra RM,Bibas BJ,Haddad R,et al.Robotic thoracic surgery for non-small cell lung cancer:initial experience in Brazil[J].J Bras Pneumol,2019,46(1):e20190003. [10]Ettinger DS,Bepler G,Bueno R,et al.Non-small cell lung cancer clinical practice guidelines in oncology[J].J Natl Compr Canc Netw,2006,4(6):548-582. [11]Veluswamy RR,Whittaker Brown SA,Mhango G,et al.Comparative Effectiveness of Robotic-Assisted Surgery for Resectable Lung Cancer in Older Patients[J].Chest,2020,157(5):1313-1321. [12]Migliore M.Robotic assisted lung resection needs further evidence[J].J Thorac Dis,2016,8(10):E1274-E1278. [13]Cerfolio RJ,Ghanim AF,Dylewski M,et al.The long-term survival of robotic lobectomy for non-small cell lung cancer:A multi-institutional study[J].J Thorac Cardiovasc Surg,2018,155(2):778-786. [14]Ahn S,Jeong JY,Kim HW,et al.Robotic lobectomy for lung cancer:initial experience of a single institution in Korea[J].Ann Cardiothorac Surg,2019,8(2):226-232. [15]Melfi FM,Menconi GF,Mariani AM,et al.Early experience with robotic technology for thoracoscopic surgery[J].Eur J Cardiothorac Surg,2002,21(5):864-868. [16]Li JT,Liu PY,Huang J,et al.Perioperative outcomes of radical lobectomies using robotic-assisted thoracoscopic technique vs.video-assisted thoracoscopic technique:retrospective study of 1,075 consecutive p-stage I non-small cell lung cancer cases[J].J Thorac Dis,2019,11(3):882-891. [17]Oh DS,Reddy RM,Gorrepati ML,et al.Robotic-Assisted,Video-Assisted Thoracoscopic and Open Lobectomy:Propensity-Matched Analysis of Recent Premier Data[J].Ann Thorac Surg,2017,104(5):1733-1740. [18]Veronesi G,Novellis P,Voulaz E,et al.Robot-assisted surgery for lung cancer:State of the art and perspectives[J].Lung Cancer,2016(101):28-34. [19]Dai F,Xu S,Xu W,et al.[A Paired Case Controlled Study Comparing the Short-term Outcomes of Da Vinci RATS and VATS Approach for Non-small Cell Lung Cancer][J].Chinese Journal of Lung Cancer,2018,21(3):206-211. [20]饶兰,张培茗,柴岗,等.基于真实世界数据的达芬奇机器人手术系统安全性研究[J].中国医学物理学杂志,2020,37(3):326-331. [21]刘新.达芬奇手术系统及其在肺癌手术中的应用[D].重庆医科大学,2017. [22]Shih YT,Shen C,Hu JC.Do Robotic Surgical Systems Improve Profit Margins?A Cross-Sectional Analysis of California Hospitals[J].Value Health,2017,20(8):1221-1225. [23]王述民,汪诚风.浅谈达芬奇机器人手术系统与电视胸腔镜系统在胸外科肺叶切除术中优劣[J].临床军医杂志,2016,44(6):551-555. [24]胡英杰,黄佳,刘晓芯.达芬奇机器人与胸腔镜在肺叶切除术中的围手术期护理对比[J].解放军医院管理杂志,2018,25(5):480-482. [25]杜宁彬,王伟峰,王猛,等.达芬奇机器人手术、胸腔镜手术及开胸手术治疗早期肺癌的疗效对比[J].现代肿瘤医学,2019,27(11):1915-1917. [26]Abbas AE.Surgical Management of Lung Cancer:History,Evolution,and Modern Advances[J].Curr Oncol Rep,2018,20(12):98. [27]Lee BE,Korst RJ,Kletsman E,et al.Transitioning from video-assisted thoracic surgical lobectomy to robotics for lung cancer:are there outcomes advantages[J].J Thorac Cardiovasc Surg,2014,147(2):724-729. [28]Procter LD,Davenport DL,Bernard AC,et al.General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay[J].J Am Coll Surg,2010,210(1):60-65.e52. [29]朱泳樵,黄佳,林皓,等.机器人辅助下胸腔镜手术(RATS)与传统胸腔镜手术(VATS)术后患者疼痛情况的比较研究[J].中国胸心血管外科临床杂志,2015,22(12):1095-1099. [30]韩露,张春敭,高凯,等.达芬奇手术机器人在恶性孤立性肺结节治疗中的临床应用[J].医药论坛杂志,2019,40(6):62-65. [31]Taniguchi Y,Nakamura H,Miwa K,et al.Initial Results of Robotic Surgery for Primary Lung Cancer:Feasibility,Safety and Learning Curve[J].Yonago Acta Med,2017,60(3):162-166. [32]Ramadan OI,Cerfolio RJ,Wei B.Tips and tricks to decrease the duration of operation in robotic surgery for lung cancer[J].J Vis Surg,2017(3):11. [33]Lardinois D,De Leyn P,Van Schil P,et al.ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer[J].Eur J Cardiothorac Surg,2006,30(5):787-792. [34]谭胜.浅论非小细胞肺癌患者术中淋巴结清除的数目与其预后的关系[J].当代医药论丛,2016(21):45-47. [35]Lardinois D,De Leyn P,Van Schil P,et al.ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer[J].Eur J Cardiothorac Surg,2006,30(5):787-792. [36]Siegel RL,Miller KD,Jemal A.Cancer statistics,2016[J].CA Cancer J Clin,2016,66(1):7-30. [37]Li JT,Liu PY,Huang J,et al.Perioperative outcomes of radical lobectomies using robotic-assisted thoracoscopic technique vs.video-assisted thoracoscopic technique:retrospective study of 1,075 consecutive p-stage I non-small cell lung cancer cases[J].J Thorac Dis,2019,11(3):882-891. [38]史博文,孙冰生,岳东升,等.达芬奇手术系统与胸腔镜在肺癌根治术中的对比分析[J].肿瘤防治研究,2018,45(2):91-95. [39]Liu X,Xu S,Liu B,et al.[Survival Analysis of Stage I Non-small Cell Lung Cancer Patients Treated with Da Vinci Robot-assisted Thoracic Surgery][J].Chinese Journal of Lung Cancer,2018,21(11):849-856. [40]Yang S,Guo W,Chen X,et al.Early outcomes of robotic versus uniportal video-assisted thoracic surgery for lung cancer:a propensity score-matched study[J].Eur J Cardiothorac Surg,2018,53(2):348-352. [41]林杰.基于倾向性评分匹配法的机器人与胸腔镜辅助肺叶切除术对早期非小细胞肺癌的近期和远期疗效比较[D].大连医科大学,2019. [42]胡博潇,刘博,许世广,等.达芬奇机器人与电视胸腔镜辅助手术治疗Ⅰ期肺腺癌远期结果的倾向性评分匹配研究[J].中国胸心血管外科临床杂志,2020,27(3):284-289. [43]孙耀光,焦鹏,田文鑫,等.全胸腔镜肺叶切除术中转开胸的临床研究[J].腹腔镜外科杂志,2016,21(9):661-665. [44]Demir A,Ayalp K,Ozkan B,et al.Robotic and video-assisted thoracic surgery lung segmentectomy for malignant and benign lesions[J].Interact Cardiovasc Thorac Surg,2015,20(3):304-309. [45]Mahieu J,Rinieri P,Bubenheim M,et al.Robot-Assisted Thoracoscopic Surgery versus Video-Assisted Thoracoscopic Surgery for Lung Lobectomy:Can a Robotic Approach Improve Short-Term Outcomes and Operative Safety[J].Thorac Cardiovasc Surg,2016,64(4):354-362. [46]Yang HX,Woo KM,Sima CS,et al.Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer:Comparison of Robotic,Video-assisted Thoracic Surgery,and Thoracotomy Lobectomy[J].Ann Surg,2017,265(2):431-437. [47]Kim MP,Nguyen DT,Meisenbach LM,et al.Da Vinci Xi robot decreases the number of thoracotomy cases in pulmonary resection[J].J Thorac Dis,2019,11(1):145-153. [48]马骏,张智光,胡芸海.胸腔镜肺叶切除术后引流量与术后肺部并发症的相关性分析[J].中国胸心血管外科临床杂志,2019(6):569-573. [49]刘星池,许世广,徐惟,等.达芬奇机器人非小细胞肺癌手术疗效分析[J].中华腔镜外科杂志(电子版),2017,10(2):97-101.
相似文献/References:
[1]尤 静.肺癌患者外周血CEA、NSE、CYFRA21-1联合检测的意义[J].医学信息,2018,31(06):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
YOU Jing.Clinical Significance of Combined Detection of CEA,NSE,CYFRA21-1 in Peripheral Blood of Patients with Lung Cancer[J].Medical Information,2018,31(23):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
[2]戴 芳,曹晓美,王莉娜.肺癌患者疾病不确定感的影响因素与干预措施研究现状[J].医学信息,2018,31(08):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
DAI Fang,CAO Xiao-mei,WANG Li-na.Research Status on Influencing Factors and Intervention Measures of Disease Uncertainty in Patients with Lung Cancer[J].Medical Information,2018,31(23):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
[3]邢益辉,刘 曼,厉玛倩倩,等.快速康复对肺癌手术患者并发症发生及生活质量的影响研究[J].医学信息,2018,31(16):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
XING Yi-hui,LIU Man,LIMA Qian-qian,et al.Effect of Rapid Rehabilitation on Complications and Quality of Life in Patients with Lung Cancer Surgery[J].Medical Information,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
[4]朱晓晓,张 顺,蔡 挺.镍暴露相关的肺癌发生分子机制研究[J].医学信息,2018,31(17):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
ZHU Xiao-xiao,ZHANG Shun,CAI Ting.Molecular Mechanism of Lung Cancer Related to Nickel Exposure[J].Medical Information,2018,31(23):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
[5]付云杰.肺癌患者血浆D-二聚体、NSE及CYFRA21-1联合检测的临床价值[J].医学信息,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
FU Yun-jie.Clinical Value of the Plasma D-dimer and Serum NSE,CYFRA21-1 Combined Detection in the Diagnosis of Lung Cancer[J].Medical Information,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
[6]覃柳麻,何慧敏.2014~2016年广西肿瘤医院肺癌患者流行病学及病理分布特征分析[J].医学信息,2019,32(05):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
QIN Liu-ma,HE Hui-min.Epidemiological and Pathological Distribution Characteristics of Lung Cancer Patients in Guangxi Cancer Hospital from 2014 to 2016[J].Medical Information,2019,32(23):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
[7]魏优蕾,郭晓彤.肺癌患者血浆检测肿瘤标志物的分析方法及展望[J].医学信息,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
WEI You-lei,GUO Xiao-Tong.Analytical Methods and Prospects of Plasma Detection of Tumor Markers in Patients with Lung Cancer[J].Medical Information,2019,32(23):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
[8]杨寿林,宋庆志,吴路发,等.肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析[J].医学信息,2019,32(07):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
YANG Shou-lin,SONG Qing-zhi,WU Lu-fa,et al.Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer[J].Medical Information,2019,32(23):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
[9]郭 磊,王小文,向小勇.中性粒细胞与淋巴细胞比值与肺癌预后关系研究[J].医学信息,2019,32(09):35.[doi:10.3969/j.issn.1006-1959.2019.09.012]
GUO Lei,WANG Xiao-wen,XIANG Xiao-yong.Relationship between Neutrophil-lymphocyte Ratio and Prognosis of Lung Cancer[J].Medical Information,2019,32(23):35.[doi:10.3969/j.issn.1006-1959.2019.09.012]
[10]王 猛.循环肿瘤细胞在肺癌诊疗中的临床研究进展[J].医学信息,2019,32(15):58.[doi:10.3969/j.issn.1006-1959.2019.15.019]
WANG Meng.Progress in Clinical Research of Circulating Tumor Cells in the Diagnosis and
Treatment of Lung Cancer[J].Medical Information,2019,32(23):58.[doi:10.3969/j.issn.1006-1959.2019.15.019]